185 related articles for article (PubMed ID: 32735530)
21. Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongenital staphylococcal infection.
Jacobson JA; Kasworm E; Daly JA
Rev Infect Dis; 1989; 11 Suppl 1():S8-13. PubMed ID: 2928655
[TBL] [Abstract][Full Text] [Related]
22. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins.
Garbe PL; Arko RJ; Reingold AL; Graves LM; Hayes PS; Hightower AW; Chandler FW; Broome CV
JAMA; 1985 May; 253(17):2538-42. PubMed ID: 3981783
[TBL] [Abstract][Full Text] [Related]
23. Vaginal community state types (CSTs) alter environmental cues and production of the
Maduta CS; McCormick JK; Dufresne K
J Bacteriol; 2024 Mar; 206(3):e0044723. PubMed ID: 38334326
[TBL] [Abstract][Full Text] [Related]
24. Rapid assay for detection of toxic shock syndrome toxin 1 from human sera.
Miwa K; Fukuyama M; Kunitomo T; Igarashi H
J Clin Microbiol; 1994 Feb; 32(2):539-42. PubMed ID: 8150970
[TBL] [Abstract][Full Text] [Related]
25. Colony immunoblot assay for the detection of staphylococcal toxic shock syndrome toxin 1 (TSST-1) with anti-TSST-1 F(ab')2 fragments.
See RH; Adilman S; Bartlett KH; Chow AW
J Clin Microbiol; 1989 Sep; 27(9):2050-3. PubMed ID: 2778069
[TBL] [Abstract][Full Text] [Related]
26. [Correlation in Staphylococcus aureus infections between toxic shock syndrome toxin-1 production and clinical feature].
Kiyota H; Ohishi Y; Onodera S; Miki K; Ueda M
Kansenshogaku Zasshi; 1998 Jun; 72(6):593-8. PubMed ID: 9695469
[TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of staphylococcal superantigens.
Salgado-Pabón W; Case-Cook LC; Schlievert PM
Methods Mol Biol; 2014; 1085():169-85. PubMed ID: 24085696
[TBL] [Abstract][Full Text] [Related]
28. Comparison of hemodynamic changes resulting from toxic shock syndrome toxin-1-producing Staphylococcus aureus sepsis and endotoxin-producing gram-negative rod sepsis in patients with severe burns.
Tanaka H; Mituo T; Yukioka T; Matsuda H; Shimazaki S; Igarashi H
J Burn Care Rehabil; 1995; 16(6):616-21. PubMed ID: 8582941
[TBL] [Abstract][Full Text] [Related]
29. Staphylococcal Enterotoxins and Toxic Shock Syndrome Toxin-1 and Their Association among Bacteremic and Infective Endocarditis Patients in Egypt.
Elsherif HM; Helal ZH; El-Ansary MR; Fahmy ZA; Eltayeb WN; Radwan S; Aboshanab KM
Biomed Res Int; 2020; 2020():6981095. PubMed ID: 33381576
[TBL] [Abstract][Full Text] [Related]
30. [Clinical aspects of streptococcal and staphylococcal toxinic diseases].
Floret D
Arch Pediatr; 2001 Sep; 8 Suppl 4():762s-768s. PubMed ID: 11582925
[TBL] [Abstract][Full Text] [Related]
31. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
De Boer ML; Kum WW; Pang LT; Chow AW
Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
[TBL] [Abstract][Full Text] [Related]
32. Toxic shock syndrome with a cytokine storm caused by Staphylococcus simulans: a case report.
Goda K; Kenzaka T; Hoshijima M; Yachie A; Akita H
BMC Infect Dis; 2021 Jan; 21(1):19. PubMed ID: 33407229
[TBL] [Abstract][Full Text] [Related]
33. Immunological protection of rabbits infected with Staphylococcus aureus isolates from patients with toxic shock syndrome.
Scott DF; Kling JM; Best GK
Infect Immun; 1986 Aug; 53(2):441-4. PubMed ID: 3733224
[TBL] [Abstract][Full Text] [Related]
34. Low incidence of toxic shock syndrome in children with staphylococcal infection.
Jacobson JA; Kasworm EM; Reiser RF; Bergdoll MS
Am J Med Sci; 1987 Dec; 294(6):403-7. PubMed ID: 3425588
[TBL] [Abstract][Full Text] [Related]
35. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
[TBL] [Abstract][Full Text] [Related]
36. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
De Boer ML; Kum WW; Chow AW
Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
[TBL] [Abstract][Full Text] [Related]
37. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period.
Takahashi N; Nishida H; Kato H; Imanishi K; Sakata Y; Uchiyama T
Lancet; 1998 May; 351(9116):1614-9. PubMed ID: 9620715
[TBL] [Abstract][Full Text] [Related]
38. Involvement of coagulase-negative staphylococci in toxic shock syndrome.
Crass BA; Bergdoll MS
J Clin Microbiol; 1986 Jan; 23(1):43-5. PubMed ID: 3700606
[TBL] [Abstract][Full Text] [Related]
39. Novel Tissue Level Effects of the Staphylococcus aureus Enterotoxin Gene Cluster Are Essential for Infective Endocarditis.
Stach CS; Vu BG; Merriman JA; Herrera A; Cahill MP; Schlievert PM; Salgado-Pabón W
PLoS One; 2016; 11(4):e0154762. PubMed ID: 27124393
[TBL] [Abstract][Full Text] [Related]
40. Toxic shock syndrome toxin 1-producing Staphylococcus aureus isolates contain the staphylococcal enterotoxin B genetic element but do not express staphylococcal enterotoxin B.
De Boer ML; Chow AW
J Infect Dis; 1994 Oct; 170(4):818-27. PubMed ID: 7930723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
